Astellas Announces Transfer of Qutenza(TM) to Grünenthal
Tokyo and Chertsey, England (ots/PRNewswire) - Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, "Astellas"), today announced that Astellas Pharma Europe Ltd., ("Astellas Pharma Europe") has entered into a definitive agreement with Grünenthal under which Astellas Pharma Europe will transfer the exclusive rights for Qutenza(TM) (capsaicin 8% patch) in Europe, Middle East and Africa to Grünenthal. (Logo: ...
mehr